PlexusDx provides compounded tirzepatide injections that work through the same mechanisms as brand medications, and addressing muscle preservation during treatment is essential for long-term health outcomes
It can be paired with metformin, a sodium-glucose cotransporter-2 inhibitor, or basal insulin to strengthen control
Consent to participate Informed consent was obtained from all individual subjects included in these trials
In a January release, the FDA said patients should not use a compounded GLP-1 drug if an approved drug, such as Wegovy, is available.
USA TODAY has contacted OKAVA Pharmaceuticals to inquire about when the implant could become available for pet owners, whether the trial is still accepting participants, and more studies are planned
Wegovy (semaglutide), manufactured by Novo Nordisk, is a GLP-1 receptor agonist that was studied in the extensive STEP clinical trial programme